Signaling lymphocyte activation molecule-associated protein is a negative regulator of the CD8 T cell response in mice

Journal of Immunology

Volumn 175, Issue 4, 2005, Pages 2212-2218

  Chen, Gang ^a   Tai, Albert K ^a   Lin, Miao ^a   Chang, Francesca ^a   Terhorst, Cox ^b   Huber, Brigitte T ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CD150 ANTIGEN; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; EPSTEIN BARR VIRUS; EX VIVO STUDY; HERPES VIRUS; HOMEOSTASIS; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; X CHROMOSOME LINKED DISORDER;

EID: 23444433656     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.4.2212     Document Type: Article

References (52)

1. Tatsumi, E., and D. T. Purtilo. 1986. Epstein-Barr virus (EBV) and X-linked lymphoproliferative syndrome (XLP). AIDS Res. 2 (Suppl. 1): S109-S113.
2. Purtilo, D. T., K. Sakamoto, V. Barnabei, J. Seeley, T. Bechtold, G. Rogers, J. Yetz, and S. Harada. 1982. Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry. Am. J. Med. 73: 49-56.
3. Sayos, J., C. Wu, M. Morra, N. Wang, X. Zhang, D. Allen, S. van Schaik, L. Notarangelo, R. Geha, M. G. Roncarolo, et al. 1998. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395: 462-469.
4. Coffey, A. J., R. A. Brooksbank, O. Brandau, T. Oohashi, G. R. Howell, J. M. Bye, A. P. Cahn, J. Durham, P. Heath, P. Wray, et al. 1998. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 20: 129-135.
5. Wu, C., J. Sayos, N. Wang, D. Howie, A. Coyle, and C. Terhorst. 2000. Genomic organization and characterization of mouse SAP, the gene that is altered in X-linked lymphoproliferative disease. Immunogenetics 51: 805-815.
6. Chan, B., A. Lanyi, H. K. Song, J. Griesbach, M. Simarro-Grande, F. Poy, D. Howie, J. Sumegi, C. Terhorst, and M. J. Eck. 2003. SAP couples Fyn to SLAM immune receptors. Nat. Cell Biol. 5: 155-160.
7. Aoukaty, A., and R. Tan. 2002. Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase. J. Biol. Chem. 277: 13331-13337.
8. Cannons, J. L., L. J. Yu, B. Hill, L. A. Mijares, D. Dombroski, K. E. Nichols, A. Antonellis, G. A. Koretzky, K. Gardner, and P. L. Schwartzberg. 2004. SAP regulates T(H)2 differentiation and PKC-θ-mediated activation of NF-κB1. Immunity 21: 693-706.
9. + T cells. J. Clin. Invest. 115: 1049-1059.
10. Davidson, D., X. Shi, S. Zhang, H. Wang, M. Nemer, N. Ono, S. Ohno, Y. Yanagi, and A. Veillette. 2004. Genetic evidence linking SAP, the X-linked lymphoproliferative gene product, to Src-related kinase FynT in T(H)2 cytokine regulation. Immunity 21: 707-717.
11. Nagy, N., C. Cerboni, K. Mattsson, A. Maeda, P. Gogolak, J. Sumegi, A. Lanyi, L. Szekely, E. Carbone, G. Klein, and E. Klein. 2000. SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines. Int. J. Cancer 88: 439-447.
12. Argov, S., D. R. Johnson, M. Collins, H. S. Koren, H. Lipscomb, and D. T. Purtilo. 1986. Defective natural killing activity but retention of lymphocyte-mediated antibody-dependent cellular cytotoxicity in patients with the X-linked lymphoproliferative syndrome. Cell. Immunol. 100: 1-9.
13. Harada, S., T. Bechtold, J. K. Seeley, and D. T. Purtilo. 1982. Cell-mediated immunity to Epstein-Barr virus (EBV) and natural killer (NK)-cell activity in the X-linked lymphoproliferative syndrome. Int. J. Cancer 30: 739-744.
14. Rousset, F., G. Souillet, M. G. Roncarolo, and J. P. Lamelin. 1986. Studies of EBV-lymphoid cell interactions in two patients with the X-linked lymphoproliferative syndrome: normal EBV-specific HLA-restricted cytotoxicity. Clin. Exp. Immunol. 63: 280-289.
15. Okano, M., G. M. Thiele, T. G. Gross, J. R. Davis, and D. T. Purtilo. 1990. Differential cellular susceptibility to Epstein-Barr virus infection in a patient with X-linked lymphoproliferative disease. J. Med. Virol. 32: 47-52.
16. Sharifi, R., J. C. Sinclair, K. C. Gilmour, P. D. Arkwright, C. Kinnon, A. J. Thrasher, and H. B. Gaspar. 2004. SAP mediates specific cytotoxic T cell functions in X-linked lymphoproliferative disease. Blood 103: 3821-3827.
17. Nakamura, H., J. Zarycki, J. L. Sullivan, and J. U. Jung. 2001. Abnormal T cell receptor signal transduction of CD4 Th cells in X-linked lymphoproliferative syndrome. J. Immunol. 167: 2657-2665.
18. Wu, C., K. B. Nguyen, G. C. Pien, N. Wang, C. Gullo, D. Howie, M. R. Sosa, M. J. Edwards, P. Borrow, A. R. Satoskar, et al. 2001. SAP controls T cell responses to virus and terminal differentiation of TH2 cells. Nat. Immunol. 2: 410-414.
19. Czar, M. J., E. N. Kersh, L. A. Mijares, G. Lanier, J. Lewis, G. Yap, A. Chen, A. Sher, C. S. Duckett, R. Ahmed, and P. L. Schwartzberg. 2001. Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP. Proc. Natl. Acad. Sci. USA 98: 7449-7454.
20. Yin, L., U. Al-Alem, J. Liang, W. M. Tong, C. Li, M. Badiali, J. J. Medard, J. Sumegi, Z. Q. Wang, and G. Romeo. 2003. Mice deficient in the X-linked lymphoproliferative disease gene sap exhibit increased susceptibility to murine γ herpesvirus-68 and hypo-gammaglobulinemia. J. Med. Virol. 71: 446-455.
21. Crotty, S., E. N. Kersh, J. Cannons, P. L. Schwartzberg, and R. Ahmed. 2003. SAP is required for generating long-term humoral immunity. Nature 421: 282-287.
22. Doherty, P. C., R. A. Tripp, A. M. Hamilton-Easton, R. D. Cardin, D. L. Woodland, and M. A. Blackman. 1997. Tuning into immunological dissonance: an experimental model for infectious mononucleosis. Curr. Opin. Immunol. 9: 477-483.
23. Flano, E., D. L. Woodland, and M. A. Blackman. 2002. A mouse model for infectious mononucleosis. Immunol. Res. 25: 201-217.
24. + peripheral blood T lymphocytes. Int. Immunol. 12: 1193-1204.
25. + T-cell lymphocytosis associated with murine γ-herpesvirus infection. Viral Immunol. 14: 391-402.
26. + T cells during murine γ-herpesvirus- induced infectious mononucleosis. Immunogenetics 53: 395-400.
27. + T cells. J. Immunol. 171: 17-21.
28. Weck, K. E., S. S. Kim, H. I. Virgin, and S. H. Speck. 1999. Macrophages are the major reservoir of latent murine γ herpesvirus 68 in peritoneal cells. J. Virol. 73: 3273-3283.
29. + T cell response during acute and persistent murine γ-herpesvirus infection. Eur. J. Immunol. 29: 1059-1067.
30. + T cell numbers are maintained during γ-herpesvirus reactivation in CD4-deficient mice. Proc. Natl. Acad. Sci. USA 95: 15565-15570.
31. Johannessen, I., and D. H. Crawford. 1999. In vivo models for Epstein-Barr virus (EBV)-associated B cell lymphoproliferative disease (BLPD). Rev. Med. Virol. 9: 263-277.
32. Wilier, D. O., and S. H. Speck. 2003. Long-term latent murine γ herpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo. J. Virol. 77: 8310-8321.
33. Tripp, R. A., A. M. Hamilton-Easton, R. D. Cardin, P. Nguyen, F. G. Behm, D. L. Woodland, P. C. Doherty, and M. A. Blackman. 1997. Pathogenesis of an infectious mononucleosis-like disease induced by a murine γ-herpesvirus: role for a viral superantigen? J. Exp. Med. 185: 1641-1650.
34. Efstathiou, S., Y. M. Ho, S. Hall, C. J. Styles, S. D. Scott, and U. A. Gompels. 1990. Murine herpesvirus 68 is genetically related to the γ herpesviruses Epstein-Barr virus and herpesvirus saimiri. J. Gen. Virol. 71: 1365-1372.
35. Efstathiou, S., Y. M. Ho, and A. C. Minson. 1990. Cloning and molecular characterization of the murine herpesvirus 68 genome. J. Gen. Virol. 71: 1355-1364.
36. Usherwood, E. J., and A. Nash. 1998. Lymphoproliferative disease induced by murine herpesvirus-68. Lab. Anim. Sci. 48: 344-345.
37. Weck, K. E., M. L. Barkon, L. I. Yoo, S. H. Speck, and H. I. Virgin. 1996. Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine γ herpesvirus 68. J. Virol. 70: 6775-6780.
38. Stewart, J. P., E. J. Usherwood, A. Ross, H. Dyson, and T. Nash. 1998. Lung epithelial cells are a major site of murine γ herpesvirus persistence. J. Exp. Med. 187: 1941-1951.
39. Usherwood, E. J., J. P. Stewart, K. Robertson, D. J. Allen, and A. A. Nash. 1996. Absence of splenic latency in murine γ herpesvirus 68-infected B cell-deficient mice. J. Gen. Virol. 77: 2819-2825.
40. Ehtisham, S., N. P. Sunil-Chandra, and A. A. Nash. 1993. Pathogenesis of murine γ herpesvirus infection in mice deficient in CD4 and CD8 T cells. J. Virol. 67: 5247-5252.
41. + T cells. J. Exp. Med. 184: 863-871.
42. + T cell response primed to a lytic-phase epitope. Proc. Natl. Acad. Sci. USA 96: 9281-9286.
43. Sullivan, J. L., K. S. Byron, F. E. Brewster, S. M. Baker, and H. D. Ochs. 1983. X-linked lymphoproliferative syndrome: natural history of the immunodeficiency. J. Clin. Invest. 71: 1765-1778.
44. Purtilo, D. T., H. L. Grierson, J. R. Davis, and M. Okano. 1991. The X-linked lymphoproliferative disease: from autopsy toward cloning the gene 1975-1990. Pediatr. Pathol. 11: 685-710
45. Seemayer, T. A., T. G. Greiner, T. G. Gross, J. R. Davis, A. Lanyi, and J. Sumegi. 2000. X-linked Lymphoproliferative Disease. Humana Press, Totowa.
46. Seemayer, T. A., T. G. Gross, R. M. Egeler, S. J. Pirruccello, J. R. Davis, C. M. Kelly, M. Okano, A. Lanyi, and J. Sumegi. 1995. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr. Res. 38: 471-478.
47. Maia, D. M., and C. P. Garwacki. 1999. X-linked lymphoproliferative disease: pathology and diagnosis. Pediatr. Dev. Pathol. 2: 72-77.
48. Weck, K. E., S. S. Kim, H. I. Virgin, and S. H. Speck. 1999. B cells regulate murine γ herpesvirus 68 latency. J. Virol. 73: 4651-4661.
49. + T cells. J. Gen. Virol. 80: 477-483.
50. Peacock, J. W., and K. L. Bost. 2001. Murine γ herpesvirus-68- induced interleukin-10 increases viral burden, but limits virus-induced splenomegaly and leukocytosis. Immunology 104: 109-117.
51. Morra, M., R. A. Barrington, A. C. Abadia-Molina, S. Okamoto, A. Julien, C. Gullo, A. Kalsy, M. J. Edwards, G. Chen, R. Spolski, et al. 2005. Defective B cell responses in the absence of SH2D1A. Proc. Natl. Acad. Sci. USA 102: 4819-4823.
52. Nichols, K. E., C. S. Ma, J. L. Cannons, P. L. Schwartzberg, and S. G. Tangye. 2005. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol. Rev. 203: 180-199.